ACKR3 and central nervous system cancer: Among the CXCR7 antagonists are CCX771 and CCX733, of which CCX771 inhibited glioma cell proliferation and invasion [110] and CCX733 reduced proliferation and antiapoptotic effects in vitro [56,111].